Docoh
Loading...

BLFS Biolife Solutions

Press releases

From Benzinga Pro
BioLife Solutions Announces Preliminary 2021 Revenue of $119 Million, Up 148% Over 2020
10 Jan 22
Earnings, Press Releases
BOTHELL, Wash., Jan. 10, 2022 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ:BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy (CGT) and broader biopharma
BioLife Solutions Collaborates with Seattle Children's to Improve Viral Vector and Cell and Gene Therapy Manufacturing
4 Jan 22
News, Contracts, Small Cap, Press Releases
BOTHELL, Wash., Jan.
UNICEF Selects Ultra-Low Temperature (ULT) Freezers from BioLife Solutions to Extend Thermal Stability of COVID-19 Vaccines
16 Dec 21
Small Cap, Press Releases
BOTHELL, Wash., Dec. 16, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ:BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader
BioLife Solutions Ranks 353 Among Fastest-Growing Companies in North America on the 2021 Deloitte Technology Fast 500™
17 Nov 21
Small Cap, Press Releases
BOTHELL, Wash., Nov.
BioLife Solutions Named to Inc. Magazine Inaugural List of Best-Led Companies
15 Nov 21
Small Cap, Press Releases
BOTHELL, Wash., Nov. 15, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ:BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for
BioLife Solutions Announces Third Quarter 2021 Financial Results
11 Nov 21
Earnings, Small Cap, Press Releases
BOTHELL, Wash., Nov. 11, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ:BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for
BioLife Solutions Announces Executive Management Changes
4 Nov 21
Small Cap, Press Releases
BOTHELL, Wash., Nov. 4, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (the "Company") (NASDAQ:BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies
BioLife Solutions to Report Third Quarter 2021 Financial Results and Provide Business Update on November 11, 2021
4 Nov 21
Small Cap, Press Releases
BOTHELL, Wash., Nov. 4, 2021 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ:BLFS), a leading supplier of class-defining bioproduction tools and services for the cell and gene therapies ("CGT") and broader
Biolife Solutions Supports Biostorage Best Practices Through SciSafe's "Centers of Excellence" With New World-Class Facility in Amsterdam
26 Oct 21
Press Releases
BOTHELL, Wash., Oct. 26, 2021 /PRNewswire/ -- Biolife Solutions, Inc. (NASDAQ:BLFS), a leading supplier of class-defining bioproduction tools and services for cell and gene therapies ("CGT"), and its biological